- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 98
Daily deal net: September 11, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 11, 2019Q-Ctrl controls for $15m investment
University of Sydney's quantum error-correction spinout Q-Ctrl has added $15m from investors including Main Sequence Ventures and plans to double its headcount and open a US office.
Sep 11, 2019Trucode extricates $34m
Trucode is advancing in vivo gene editing applications for disorders including sickle cell disease that grew from Yale research and has been backed by GV and Kleiner Perkins.
Sep 11, 2019Daily deal net: September 10, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 10, 2019Yasa fires up $22m
University of Oxford's electric motor spinout Yasa has added $22m from investors including OSI and Parkwalk Advisors to its coffers to help it cope with growing customer demand.
Sep 10, 2019Corporate venturing deal net: 2-6 September 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Sep 6, 2019Cartica AI clinches series B funding
Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.
Sep 5, 2019Guiji Zhineng gets series B-plus cash
The Tencent-backed enterprise automation technology supplier has raised hundreds of millions of renminbi in a round led by CMB Telecom.
Sep 4, 2019VIPThink invites New Oriental to series B round
The mathematics learning platform has raised a nine-figure renminbi amount in a New Oriental-led round that included Ximalaya FM.
Sep 4, 2019Caldan calls in $2.4m
Leveraging University of Glasgow and University of Southern Denmark research, Caldan is targeting a free fatty acid receptor associated with fatty liver disease and type 2 diabetes.
Sep 4, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


